SCHEMBL31545765

SCHEMBL31545765

C=C(O)C(C)(C)c1cc(O)c(C2CCC=C(C)C2)c(OC(C)C)c1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31546028 0.84 CNR1 (0.33) CNR2
SCHEMBL21665458 0.81 CNR1 (0.32)
SCHEMBL31545876 0.81 CNR1 (0.46) CNR2
SCHEMBL12956669 0.78 CNR1 (0.34) CNR2
SCHEMBL31545613 0.77 CNR1 (0.40) CNR2
SCHEMBL14625806 0.75 CNR1 (0.38) CNR2
SCHEMBL22705376 0.74 ADRA1D (0.35) CNR2
SCHEMBL31545552 0.73 CNR2 (0.47) CNR2
SCHEMBL22705342 0.72 OPRM1 (0.47) CNR2
SCHEMBL22705440 0.72 OPRM1 (0.46) CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 US disclosed